Whether you accept it, avoid it or live somewhere in between, insurance coverage has become a defining issue for our profession. Patients increasingly expect to use their benefits, practitioners want to be compensated fairly for their time and expertise, and the system itself remains – at best – fragmented. The encouraging news is that coverage has expanded in meaningful ways. The challenging news is that reimbursement, across the board, remains inadequate.
Michelle Shine, PhD
Michelle Shine serves as a biomedical scientist in the hemp industry. She has worked on the cutting edge of biotechnology, and has published peer-reviewed articles in the fields of stem cell therapy, tissue engineering, and more. You may email Michelle at Michelle@HempMagik.com.